Uncertainty Over U.S. Tariffs Boosts Safe-Haven Demand, Driving Precious Metals Higher
Following the U.S. Supreme Court’s rejection of several tariff measures Donald Trump, uncertainty surrounding the policy outlook has driven investors to seek refuge in precious metals, pushing gold prices higher. Market analyst Kyle Rodda stated, “The return of the Chinese market, coupled with increased policy uncertainty in the U.S., is maintaining the appeal of gold and silver to some extent.”” Meanwhile, two Federal Reserve officials hinted that they have no intention of changing the central bank’s interest rate policy in the short term. The market currently expects three 25-basis-point rate cuts this year. “Gold prices still have ample room to rise, especially if all the factors driving the price higher—such as U.S. fiscal and trade policies, as well as foreign policy—persist.”"On the geopolitical front, Oman’s foreign minister previously stated that the U.S. and Iran will hold a third round of nuclear talks in Geneva on Thursday. As of this writing, spot gold is up over 1%, while spot silver and spot platinum are both up over 4%, and spot palladium is up more than 2%."
Source:富途快讯 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
4
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
7
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
8
MARA Stock Valuation Analysis: Marathon Digital Holdings’ Transition to AI and Long-Term Investment Outlook
-
9
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
10
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
Markets Today
Recommended Reading










